Physician

Amit Asija, M.D.

According to 2025 Medicare claims, Amit Asija, M.D. (NPI: 1699907790) practices pulmonary disease in the Charlotte-Concord-Gastonia, NC-SC market, with the plurality of this provider's patient population coming from Mecklenburg, NC. This provider's primary affiliated billing organization is NOVANT HEALTH MEDICAL GROUP, LLC (NPI: 1073235230; TIN: 581728803) and primary practice location at 28105-2389. Asija is affiliated with the Novant Health Accountable Care Organization I, LLC (ACO ID: A3504), participating under the MSSP model.

Asija's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 346 traditional Medicare patients, billed 1,302 HCPCS/CPT codes, and received $80,384 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 1,995 prescription claims across 344 beneficiaries totaling $999,574 in drug costs, led by Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter). DME data shows 572 claims. Open Payments data shows 12 records totaling $5,078. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a higher plateau to a lower plateau, from $185,262 to $80,384. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $161,865 and ending at $999,574. For DME billing, reported payments moved from a higher plateau to a lower plateau, from $57,130 to $30,731.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	654	2,963	$185,262
2016	691	2,937	$194,096
2017	541	1,984	$159,532
2018	339	1,303	$110,270
2019	492	1,617	$135,703
2020	440	1,224	$95,642
2021	466	1,415	$113,610
2022	385	1,203	$94,118
2023	385	1,206	$87,489
2024	346	1,302	$80,384

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	153	679	$161,865
2016	221	1,380	$693,793
2017	168	1,207	$730,722
2018	129	441	$355,176
2019	124	525	$347,852
2020	131	650	$606,520
2021	135	568	$615,205
2022	204	880	$354,579
2023	285	1,673	$973,935
2024	344	1,995	$999,574

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	212	659	$43,549
2016	371	1,508	$88,362
2017	274	1,219	$83,215
2018	120	615	$48,099
2019	126	583	$69,018
2020	105	545	$64,101
2021	36	506	$40,765
2022	38	355	$21,824
2023	121	575	$36,694
2024	140	572	$36,536

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	76	76	$113
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	134	190	$90
94729	Test to examine how well the lungs exchange gases	77	77	$26
94010	Test to measure expiratory airflow and volume	84	88	$16
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	88	114	$12

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	353	12,784	$266,831
Prolastin C	Alpha-1-Proteinase Inhibitor	15	420	$151,784
Breo Ellipta	Fluticasone/Vilanterol	224	8,490	$110,029
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	98	4,110	$61,914
Nucala	Mepolizumab	11	308	$41,386

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J7677	Revefenacin inhalation solution, fda-approved final product, non-compounded, administered through dme, 1 microgram	N	N/R	18	$13,710
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	16	76	$5,531
A7031	Face mask interface, replacement for full face mask, each	N	13	33	$2,995
A7030	Full face mask used with positive airway pressure device, each	N	14	31	$2,889
E1392	Portable oxygen concentrator, rental	Y	N/R	36	$1,335

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	12	$5,078	INTUITIVE SURGICAL, INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Amit Asija, M.D.?

Tedicare shows public-source Medicare data for Amit Asija, M.D. (NPI 1699907790), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Amit Asija, M.D. have ACO affiliation data?

Amit Asija, M.D. is shown with ACO affiliation data for Novant Health Accountable Care Organization I, LLC (MSSP, ACO ID A3504).

What billing organization is linked to Amit Asija, M.D.?

Amit Asija, M.D. is linked to NOVANT HEALTH MEDICAL GROUP, LLC (billing NPI 1073235230) in the available physician profile data.

Does Amit Asija, M.D. have Open Payments data?

Amit Asija, M.D. has 12 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.